Tiblio
Sign Up

AFYA

Afya Ltd
NASDAQCONSUMER DEFENSIVEEDUCATION & TRAINING SERVICES

Key Statistics

Market Cap
$1.15B
P/E Ratio
7.78
EPS
$1.67
Beta
0.38
52W High
$16.16
52W Low
$12.45
50-Day MA
$14.00
200-Day MA
$14.39
Dividend Yield
5.05%
Profit Margin
20.40%
Forward P/E
7.86
PEG Ratio
—

About Afya Ltd

Afya Limited, is a medical education group in Brazil. The company is headquartered in Nova Lima, Brazil.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$3.83B
Gross Profit (TTM)$2.45B
EBITDA$1.49B
Operating Margin30.60%
Return on Equity16.70%
Return on Assets8.41%
Revenue/Share (TTM)$42.59
Book Value$10.64
Price-to-Book1.25
Price-to-Sales (TTM)0.30
EV/Revenue2.151
EV/EBITDA4.79
Quarterly Earnings Growth (YoY)17.60%
Quarterly Revenue Growth (YoY)5.70%
Shares Outstanding$49.90M
Float$5.74M
% Insiders78.20%
% Institutions20.14%

Historical Volatility

HV 10-Day
28.76%
HV 20-Day
29.79%
HV 30-Day
29.88%
HV 60-Day
27.87%
HV Rank
73.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($17.10 target)
1
Strong Buy
5
Hold
3
Sell

Latest News

Afya Limited and Yduqs Participações S.A. Enter Into Merger Agreement

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), announced today that it has entered into a binding merger agreement with Yduqs Participações S.A. (B3: YDUQ3) (“Yduqs” and, together with Afya, the “Companies”) providing for a business combination of the two companies (the “Proposed Transaction”). The Proposed Transaction brings together two major Brazilian higher education platforms. Afya is one of Brazil's leading medical education gro.

Business Wire9/24/2026Neutral
Afya Got Some Regulatory Respite But The Education Quality Risk Remains

Afya Limited (AFYA) reported 2Q26 results showing revenue up 6% YoY, barely above inflation, with margin contraction and slowing student growth. Regulatory risks from ENAMED exam results persist, threatening both seat capacity and brand reputation, despite a temporary injunction lifting some restrictions. Pricing power has weakened, with tuition increases now only matching inflation, undermining the previous thesis of premium pricing for medical seats.

Seeking Alpha8/28/2026Neutral
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates

Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago.

Zacks Investment Research8/14/2026Negative
Afya Limited Announces Results of Annual General Meeting Held on June 22, 2026

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolution set out in its Notice of Annual General Meeting dated June 2, 2026 was duly passed at its Annual General Meeting held today: the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2025. About Afya Limited Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end p.

Business Wire6/22/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AFYA and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER DEFENSIVE Stocks

WMTWalmart Inc.COSTCostco Wholesale CorpKOThe Coca-Cola CompanyPGProcter & Gamble CompanyPMPhilip Morris International IncPEPPepsiCo IncBUDAnheuser Busch Inbev NV ADRULUnilever PLC ADRBTIBritish American Tobacco p.l.c.MOAltria GroupMNSTMonster Beverage CorpMDLZMondelez International Inc
View all CONSUMER DEFENSIVE stocks →
Data last updated: 9/28/2026